[ Price : $8.95]
The 3rd Circuit Appeals Court upholds a lower court ruling dismissing a whistleblower suit brought by the federal government and s...[ Price : $8.95]
FDA issues Allergan a complete response letter on its NDA for ulipristal acetate, indicated for treating abnormal uterine bleeding...[ Price : $8.95]
Federal Register notice: FDA announces a 10/19 public meeting entitled Standardized Data for Pharmaceutical Quality/Chemistry Manu...[ Price : $8.95]
Federal Register notice: FDA determines that Ditropan XL (oxybutynin chloride) extended release tablets 15mg were not withdrawn fr...[ Price : $8.95]
FDA clears a MagVenture 510(k) for a faster treatment protocol for its Transcranial Magnetic Stimulation and its use in treating d...[ Price : $8.95]
FDA approves Dompe Farmaceuticis Oxervate to treat neurotrophic keratitis, the first for this disease.[ Price : $8.95]
FDA issues a complete response letter with recommendations for resubmitting Malinckrodys NDA for stannsoporfin.[ Price : $8.95]
Federal Register notice: FDA announces a 9/20 public meeting entitled Expanding Access to Effective Treatment for Opioid Use Disor...